Inventor · disambiguated record
Nicholas J. Virca
Also filed as: VIRCA NICHOLAS J
6 granted patents·7 pending applications·143 citations·filing 1987–2020
80Inventor score
Top patents by PatentIndex Score
13 records- 0195US4753358AVial cap coupling devicePROMEGA CORP·Filed 1987·Granted Jun 28, 1988·141 cites·22 claims
- 0277US9968600B2Treatment and prognostic monitoring of non-cancerous proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2017·Granted May 15, 2018·1 cites·19 claims
- 0374US2020375985A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsINHIBITOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0470US9192609B2Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH LLC·Filed 2014·Granted Nov 24, 2015·1 cites·33 claims
- 0568US2019255044A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0668US2019255045A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0767US10363252B2Treatment of prostate cancer using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2018·Granted Jul 30, 2019·0 cites·20 claims
- 0867US10328072B2Treatment of lung cancer using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·24 claims
- 0964US9962381B2Treatment and prognostic monitoring of cancerous proliferation disorders using Hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2017·Granted May 8, 2018·0 cites·21 claims
- 1059US2016074392A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1159US2016074393A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1248US2019365743A1Hedgehog pathway inhibition for treatment of high-risk basal cell carcinoma or high-risk basal cell carcinoma nevus syndromeHEDGEPATH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1348US2019365742A1Azole treatment regimen with reduced hepatotoxicityHEDGEPATH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas J. Virca files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →